Vaccines Market Size, Trends, Analysis, and Outlook By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Viral Vector Vaccines, m-RNA Vaccines, Others), By Type (Monovalent Vaccines, Mulitvalent Vaccines), By Disease (Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, Others), By Route of Administration (Intramuscular, Subcutaneous, Oral, Others), By End-User (Pediatric Vaccine, Adult Vaccine), by Country, Segment, and Companies, 2024-2032
The global Vaccines market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Vaccines market across By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Viral Vector Vaccines, m-RNA Vaccines, Others), By Type (Monovalent Vaccines, Mulitvalent Vaccines), By Disease (Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, Others), By Route of Administration (Intramuscular, Subcutaneous, Oral, Others), By End-User (Pediatric Vaccine, Adult Vaccine)
With the increasing focus on preventive healthcare and the growing prevalence of infectious diseases, there is a rising demand for vaccines to prevent illness and promote public health. Market growth is driven by factors such as expanding immunization programs, technological advancements in vaccine development and production, and the rising awareness about the benefits of vaccination. Additionally, the growing investment in vaccine research and development, the emergence of novel vaccine platforms, and the increasing adoption of combination vaccines contribute to market expansion. Further, the development of vaccines for emerging infectious diseases and the expansion of vaccination coverage in developing countries are expected to further propel market growth in the coming years.
Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Vaccines industry.
Key market trends defining the global Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Vaccines industry
Leading Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Vaccines companies.
Vaccines Market Study- Strategic Analysis Review
The Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Vaccines Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Vaccines market segments. Similarly, Strong market demand is encouraging Canadian Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Vaccines in Asia Pacific. In particular, China, India, and South East Asian Vaccines markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Vaccines.
Vaccines Market Company Profiles
The global Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca PLC, Bavarian Nordic A/S, Bharat Biotech International Ltd, Bio Farma, Biological E Ltd, CSL Ltd, Daiichi Sankyo Company Ltd, Emergent BioSolutions Inc, FSUE NPO Microgen, GlaxoSmithKline plc, Indian Immunologicals Ltd, Inovio Pharmaceuticals Inc, Johnson & Johnson Services Inc, Merck & Co. Inc, Mitsubishi Tanabe Pharma Corp, Novavax Inc, Panacea Biotec Ltd, Pfizer Inc, Sanofi SA, Serum Institute of India Private Ltd, Sinovac Incepta Pharmaceuticals, Valneva SE, VBI Vaccines Inc, Zhi Fei Biological Products Co. Ltd.
Recent Vaccines Market Developments
The global Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Technology
Conjugate Vaccines
Recombinant Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Viral Vector Vaccines
m-RNA Vaccines
Others
By Type
Monovalent Vaccines
Mulitvalent Vaccines
By Disease
Pneumococcal Disease
Influenza
Combination Vaccines
HPV
Meningococcal Disease
Herpes Zoster
Rotavirus
MMR
Varicella
Hepatitis
DTP
Polio
Others
By Route of Administration
Intramuscular
Subcutaneous
Oral
Others
By End-User
Pediatric Vaccine
Adult Vaccine
Geographical Segmentation:
AstraZeneca PLC
Bavarian Nordic A/S
Bharat Biotech International Ltd
Bio Farma
Biological E Ltd
CSL Ltd
Daiichi Sankyo Company Ltd
Emergent BioSolutions Inc
FSUE NPO Microgen
GlaxoSmithKline plc
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Johnson & Johnson Services Inc
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Panacea Biotec Ltd
Pfizer Inc
Sanofi SA
Serum Institute of India Private Ltd
Sinovac Incepta Pharmaceuticals
Valneva SE
VBI Vaccines Inc
Zhi Fei Biological Products Co. Ltd
Formats Available: Excel, PDF, and PPT
With the increasing focus on preventive healthcare and the growing prevalence of infectious diseases, there is a rising demand for vaccines to prevent illness and promote public health. Market growth is driven by factors such as expanding immunization programs, technological advancements in vaccine development and production, and the rising awareness about the benefits of vaccination. Additionally, the growing investment in vaccine research and development, the emergence of novel vaccine platforms, and the increasing adoption of combination vaccines contribute to market expansion. Further, the development of vaccines for emerging infectious diseases and the expansion of vaccination coverage in developing countries are expected to further propel market growth in the coming years.
Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Vaccines industry.
Key market trends defining the global Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Vaccines industry
Leading Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Vaccines companies.
Vaccines Market Study- Strategic Analysis Review
The Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Vaccines Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Vaccines market segments. Similarly, Strong market demand is encouraging Canadian Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Vaccines in Asia Pacific. In particular, China, India, and South East Asian Vaccines markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Vaccines.
Vaccines Market Company Profiles
The global Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca PLC, Bavarian Nordic A/S, Bharat Biotech International Ltd, Bio Farma, Biological E Ltd, CSL Ltd, Daiichi Sankyo Company Ltd, Emergent BioSolutions Inc, FSUE NPO Microgen, GlaxoSmithKline plc, Indian Immunologicals Ltd, Inovio Pharmaceuticals Inc, Johnson & Johnson Services Inc, Merck & Co. Inc, Mitsubishi Tanabe Pharma Corp, Novavax Inc, Panacea Biotec Ltd, Pfizer Inc, Sanofi SA, Serum Institute of India Private Ltd, Sinovac Incepta Pharmaceuticals, Valneva SE, VBI Vaccines Inc, Zhi Fei Biological Products Co. Ltd.
Recent Vaccines Market Developments
The global Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Technology
Conjugate Vaccines
Recombinant Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Viral Vector Vaccines
m-RNA Vaccines
Others
By Type
Monovalent Vaccines
Mulitvalent Vaccines
By Disease
Pneumococcal Disease
Influenza
Combination Vaccines
HPV
Meningococcal Disease
Herpes Zoster
Rotavirus
MMR
Varicella
Hepatitis
DTP
Polio
Others
By Route of Administration
Intramuscular
Subcutaneous
Oral
Others
By End-User
Pediatric Vaccine
Adult Vaccine
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AstraZeneca PLC
Bavarian Nordic A/S
Bharat Biotech International Ltd
Bio Farma
Biological E Ltd
CSL Ltd
Daiichi Sankyo Company Ltd
Emergent BioSolutions Inc
FSUE NPO Microgen
GlaxoSmithKline plc
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Johnson & Johnson Services Inc
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Panacea Biotec Ltd
Pfizer Inc
Sanofi SA
Serum Institute of India Private Ltd
Sinovac Incepta Pharmaceuticals
Valneva SE
VBI Vaccines Inc
Zhi Fei Biological Products Co. Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Vaccines Market Overview and Key Findings, 2024
1.2 Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Vaccines Market Growth Opportunities to 2030
1.4 Key Vaccines Market Trends and Challenges
1.4.1 Vaccines Market Drivers and Trends
1.4.2 Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Vaccines Companies
2. VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Technology
Conjugate Vaccines
Recombinant Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Viral Vector Vaccines
m-RNA Vaccines
Others
By Type
Monovalent Vaccines
Mulitvalent Vaccines
By Disease
Pneumococcal Disease
Influenza
Combination Vaccines
HPV
Meningococcal Disease
Herpes Zoster
Rotavirus
MMR
Varicella
Hepatitis
DTP
Polio
Others
By Route of Administration
Intramuscular
Subcutaneous
Oral
Others
By End-User
Pediatric Vaccine
Adult Vaccine
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Vaccines Market, 2025
5.2 Asia Pacific Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Vaccines Market, 2025
5.5 Europe Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Vaccines Market, 2025
5.8 North America Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Vaccines Market, 2025
5.11 South America Pacific Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Vaccines Market, 2025
5.14 Middle East Africa Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Vaccines Industry Drivers and Opportunities
7. VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. VACCINES COMPANY PROFILES
8.1 Profiles of Leading Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca PLC
Bavarian Nordic A/S
Bharat Biotech International Ltd
Bio Farma
Biological E Ltd
CSL Ltd
Daiichi Sankyo Company Ltd
Emergent BioSolutions Inc
FSUE NPO Microgen
GlaxoSmithKline plc
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Johnson & Johnson Services Inc
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Panacea Biotec Ltd
Pfizer Inc
Sanofi SA
Serum Institute of India Private Ltd
Sinovac Incepta Pharmaceuticals
Valneva SE
VBI Vaccines Inc
Zhi Fei Biological Products Co. Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Vaccines Market Overview and Key Findings, 2024
1.2 Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Vaccines Market Growth Opportunities to 2030
1.4 Key Vaccines Market Trends and Challenges
1.4.1 Vaccines Market Drivers and Trends
1.4.2 Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Vaccines Companies
2. VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Technology
Conjugate Vaccines
Recombinant Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Viral Vector Vaccines
m-RNA Vaccines
Others
By Type
Monovalent Vaccines
Mulitvalent Vaccines
By Disease
Pneumococcal Disease
Influenza
Combination Vaccines
HPV
Meningococcal Disease
Herpes Zoster
Rotavirus
MMR
Varicella
Hepatitis
DTP
Polio
Others
By Route of Administration
Intramuscular
Subcutaneous
Oral
Others
By End-User
Pediatric Vaccine
Adult Vaccine
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Vaccines Market, 2025
5.2 Asia Pacific Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Vaccines Market, 2025
5.5 Europe Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Vaccines Market, 2025
5.8 North America Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Vaccines Market, 2025
5.11 South America Pacific Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Vaccines Market, 2025
5.14 Middle East Africa Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Vaccines Industry Drivers and Opportunities
7. VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. VACCINES COMPANY PROFILES
8.1 Profiles of Leading Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca PLC
Bavarian Nordic A/S
Bharat Biotech International Ltd
Bio Farma
Biological E Ltd
CSL Ltd
Daiichi Sankyo Company Ltd
Emergent BioSolutions Inc
FSUE NPO Microgen
GlaxoSmithKline plc
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Johnson & Johnson Services Inc
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Panacea Biotec Ltd
Pfizer Inc
Sanofi SA
Serum Institute of India Private Ltd
Sinovac Incepta Pharmaceuticals
Valneva SE
VBI Vaccines Inc
Zhi Fei Biological Products Co. Ltd.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
